Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies

B Kuttler, K Rösing, M Lehmann, J Brock… - Journal of molecular …, 1999 - Springer
Grafting autoimmune-diabetic recipients with allogeneic islets, graft rejection and disease
recurrence as major problems of reaching indefinite survival and tolerance induction have to …

Anti-CD8 Abrogates Effect of Anti-CD4–Mediated Islet Allograft Survival in Rat Model

K Seydel, J Shizuru, D Grossman, A Wu, S Alters… - Diabetes, 1991 - Am Diabetes Assoc
We studied the effects of anti-CD4 treatment of diabetic ACI rats on the induction oftolerance
to allogeneic (Lewis) islet allografts. When given as a 4-day treatment regimen, OX38, a …

Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic NOD mice from …

Z Guo, T Wu, N Kirchhof, D Mital, JW Williams… - …, 2001 - journals.lww.com
Background. T-cell activation and the subsequent induction of effector functions require not
only the recognition of antigen peptides bound to MHC molecules by T-cell receptor (TCR) …

Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice1

M Drage, P Zaccone, JM Phillips, F Nicoletti… - …, 2002 - journals.lww.com
Background. Successful islet transplantation in type 1 diabetes requires tolerance induction
of both allo-and autoreactive T-cell responses. Monoclonal antibodies targeting the CD4 …

Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats

B Kuttler, C Kauert, H Wanka, T Diamantstein… - Journal of …, 1996 - Elsevier
Pancreatic islets obtained from the congenic LEW. 1BB/OK rat strain (MHC identical,
different in genetic background from BB/OK rats) were grated into diabetic BB/OK rats. The …

[引用][C] Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats

B Kuttler, K Rösing, HJ Hahn - Transplantation Proceedings, 1997 - Elsevier
MATERIALS AND METHODS All rat strains used were bred in the Animal Laboratories of the
Institute of Diabetes “Gerhardt Katsch,” Karlsburg, Germany. Diabetic BBiOK rats (RT. l”, n …

BLOCKADE OF CD4 MOLECULES BY NONDEPLETING ANTI-CD4 MONOCLONAL ANTIBODIES PREVENTS XENOGENEIC PIG ISLET GRAFT REJECTION AND …

Z Guo, BJ Hering, D Mital, Y Huang, J Shen, T Wu… - …, 1999 - journals.lww.com
CD4+ T cells play a major role in xenogeneic islet graft rejection and recurrence of
autoimmune diabetes after islet transplantation. CD4 molecule is required as a co-receptor …

Anti‐CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes

C Hu, S Deng, FS Wong, L Wen - … of the New York Academy of …, 2008 - Wiley Online Library
Type 1 diabetes is an autoimmune disease characterized by T cell–mediated destruction of
pancreatic islet beta cells. Pancreatic islet transplantation with long‐term …

EFFECT OF THERAPY WITH NON-DEPLETING ANTI-CD4 MONOCLONAL ANTIBODY AND CTLA4IG ON ALLOGENEIC ISLET GRAFT SURVIVAL IN AUTOIMMUNE …

Z Guo, T Wu, AM Trexler, S Nevile, N Kirchhof… - …, 2000 - journals.lww.com
EFFECT OF THERAPY WITH NON-DEPLETING ANTI-CD4 MONOCLONAL ANT... :
Transplantation EFFECT OF THERAPY WITH NON-DEPLETING ANTI-CD4 MONOCLONAL …

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies

PL Mottram, LJ Murray-Segal, W Han, J Maguire… - Transplant …, 2002 - Elsevier
Diabetes in NOD mice is an autoimmune disease similar to Type I diabetes in humans. Prior
to hypoglycemia, changes in the islet infiltrate led to autoreactive T cell activation and …